Millennium Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-70,000
Closed -$1.87M – 6083
2024
Q3
$1.87M Buy
+70,000
New +$1.39M ﹤0.01% 3763

Other funds holding EWTX

Millennium Management's EWTX Position: Q3 2026 in Review

Millennium Management opened a new position in Edgewise Therapeutics (EWTX) in Q3 2026: 33,479 shares worth $1.36M. The stake represents ﹤0.01% of the portfolio and ranks #4225 among its holdings. This is a return to the name: Millennium Management previously reported a position in EWTX as recently as Q1 2026.

Millennium Management first reported a position in EWTX in Q1 2021 and has held it in 17 quarters since. The position peaked at $26.3M in Q3 2024. 253 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • Millennium Management held 33,479 shares of Edgewise Therapeutics worth $1.36M as of Q3 2026.
  • Edgewise Therapeutics was a new Millennium Management position in Q3 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #4225 holding.
  • Millennium Management first reported a position in Edgewise Therapeutics in Q1 2021 and has held it in 17 quarters since.
  • Millennium Management's Edgewise Therapeutics position peaked at $26.3M in Q3 2024.
  • 253 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.